Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Courses / 8
Choose to watch or read lectures at your convenience and earn CME credits.
Modification of Systemic MTSAD Treatment Protocols in the COVID Pandemic Environment and When Considering COVID Vaccination
Overview and case discussion of COVID-19 infection and vaccination in patients with moderate-to-severe atopic dermatitis. The potential interference of COVID-19 vaccine immunogenicity for patients on biologics and immunosuppressants will be considered. Considerations for modifications of immunosuppressant dosage surrounding current COVID-19 vaccinations will be discussed.
Review of COVID Vaccine Mechanisms of Action and How Immunomodulatory Medications May Modify the Immune Response to COVID Vaccination
The COVID pandemic has given everyone a crash course in immunology. However, what we learn from the news doesn’t capture the complexity of how our immune system deals with this particular virus. In this course, we will review the immune response to infectious disease as well as how SARS-CoV2 modifies this response. We will discuss the microbiome-immune interface and factors that impact our immune response to infectious disease and vaccination. Finally, we will discuss the latest research on COVID vaccines, including vaccine side effects, booster shots, and the strategy for vaccinating children.
Safety of Vaccines and Immunosuppression
With the rise in vaccinations for COVID-19 and the need for boosters in the future, the safety for those on immunomodulating and immunosuppressive medications needs to be considered. This webinar panel discusses immunosuppressants and biologic adjustments based on vaccinations and COVID-19 with case-based examples.
Practical Approaches to Teledermatology: Billing, Coding, and More
Are you new to teledermatology or want to optimize your telederm visits? In this webinar, we share secrets to success when implementing new teledermatology approaches to patient care, including time-based billing and which rules to use, coding, documentation, precautions when seeing pediatric patients, and features to look for in a platform!
Covid 19 and Management of Pediatric Patients
In this webinar, we discuss skin signs of a COVID-19 infection in children, the risks of using biologics to treat pediatric patients, and managing the use of isotretinoin for acne.
Managing Use of Biologics: HS, Psoriasis, Atopic Dermatitis, and Beyond
In this webinar, we review the use of biologics during COVID-19 in diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. Using a case-based approach, the discussions cover a summary of immunosuppressive actions for the different biologics, risk for use in infection, considerations when choosing between biologics, and accounting for a patient’s comorbidities.
Managing Use of Systemic Immunosuppressive Medications: HS, Psoriasis, Atopic Dermatitis, Bullous Diseases, and Beyond
General immunosuppression can heighten the risk for infections, and this webinar will detail the risk for viral infections with immunosuppression and discuss strategies for immunosuppressive and immunomodulatory medication management during the COVID-19 pandemic.
Strategies for Spironolactone and Isotretinoin Use in Acne and HS
In this webinar, we review the basic virology of COVID-19 (SARS-CoV-2), including the cellular entry pathways through the ACE2 receptor. We then discuss the use of spironolactone and its possible association to ACE2 expression. We conclude with case studies and explore the use of isotretinoin from a practical perspective in the setting of physically distant management and COVID-19 infection.
